The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Monick, M. M.
Right arrow Articles by Hunninghake, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monick, M. M.
Right arrow Articles by Hunninghake, G. W.
The Journal of Immunology, 2006, 177: 1636-1645.
Copyright © 2006 by The American Association of Immunologists

Active ERK Contributes to Protein Translation by Preventing JNK-Dependent Inhibition of Protein Phosphatase 11

Martha M. Monick2, Linda S. Powers, Thomas J. Gross, Dawn M. Flaherty, Christopher W. Barrett and Gary W. Hunninghake

University of Iowa Carver College of Medicine and Veterans Administration Medical Center, Iowa City, IA 52242

Human alveolar macrophages, central to immune responses in the lung, are unique in that they have an extended life span in contrast to precursor monocytes. We have shown previously that the ERK MAPK (ERK) pathway is constitutively active in human alveolar macrophages and contributes to the prolonged survival of these cells. We hypothesized that ERK maintains survival, in part, by positively regulating protein translation. In support of this hypothesis, we have found novel links among ERK, JNK, protein phosphatase 1 (PP1), and the eukaryotic initiation factor (eIF) 2{alpha}. eIF2{alpha} is active when hypophosphorylated and is essential for initiation of protein translation (delivery of initiator tRNA charged with methionine to the ribosome). Using [35S]methionine labeling, we found that ERK inhibition significantly decreased protein translation rates in alveolar macrophages. Decreased protein translation resulted from phosphorylation (and inactivation) of eIF2{alpha}. We found that ERK inhibition increased JNK activity. JNK in turn inactivated (via phosphorylation) PP1, the phosphatase responsible for maintaining the hypophosphorylated state of eIF2{alpha}. As a composite, our data demonstrate that in human alveolar macrophages, constitutive ERK activity positively regulates protein translation via the following novel pathway: active ERK inhibits JNK, leading to activation of PP1{alpha}, eIF2{alpha} dephosphorylation, and translation initiation. This new role for ERK in alveolar macrophage homeostasis may help to explain the survival characteristic of these cells within their unique high oxygen and stress microenvironment.




This article has been cited by other articles:


Home page
Toxicol SciHome page
H. K. Bae and J. J. Pestka
Deoxynivalenol Induces p38 Interaction with the Ribosome in Monocytes and Macrophages
Toxicol. Sci., September 1, 2008; 105(1): 59 - 66.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. M. Monick, L. S. Powers, C. W. Barrett, S. Hinde, A. Ashare, D. J. Groskreutz, T. Nyunoya, M. Coleman, D. R. Spitz, and G. W. Hunninghake
Constitutive ERK MAPK Activity Regulates Macrophage ATP Production and Mitochondrial Integrity
J. Immunol., June 1, 2008; 180(11): 7485 - 7496.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. M. Thiaville, Y.-X. Pan, A. Gjymishka, C. Zhong, R. J. Kaufman, and M. S. Kilberg
MEK Signaling Is Required for Phosphorylation of eIF2{alpha} following Amino Acid Limitation of HepG2 Human Hepatoma Cells
J. Biol. Chem., April 18, 2008; 283(16): 10848 - 10857.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.